Literature DB >> 26457906

SNPs and prognosis of GvHD before HCT: any progress?

M I Abu Zaid1, S Paczesny1,2, D B Miklos3.   

Abstract

Mesh：

Year:  2015        PMID： 26457906     DOI： 10.1038/bmt.2015.240

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  17 in total

1.  Common genetic variation at the IL1RL1 locus regulates IL-33/ST2 signaling.

Authors:  Jennifer E Ho; Wei-Yu Chen; Ming-Huei Chen; Martin G Larson; Elizabeth L McCabe; Susan Cheng; Anahita Ghorbani; Erin Coglianese; Valur Emilsson; Andrew D Johnson; Stefan Walter; Nora Franceschini; Christopher J O'Donnell; Abbas Dehghan; Chen Lu; Daniel Levy; Christopher Newton-Cheh; Honghuang Lin; Janine F Felix; Eric R Schreiter; Ramachandran S Vasan; James L Januzzi; Richard T Lee; Thomas J Wang
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

2.  A UGT2B17-positive donor is a risk factor for higher transplant-related mortality and lower survival after bone marrow transplantation.

Authors:  Seitaro Terakura; Makoto Murata; Tetsuya Nishida; Nobuhiko Emi; Yoshiki Akatsuka; Stanley R Riddell; Yasuo Morishima; Yoshihisa Kodera; Tomoki Naoe
Journal:  Br J Haematol       Date:  2005-04       Impact factor: 6.998

3.  Target antigens determine graft-versus-host disease phenotype.

Authors:  Daniel H Kaplan; Britt E Anderson; Jennifer M McNiff; Dhanpat Jain; Mark J Shlomchik; Warren D Shlomchik
Journal:  J Immunol       Date:  2004-11-01       Impact factor: 5.422

Review 4.  Defining genetic risk for graft-versus-host disease and mortality following allogeneic hematopoietic stem cell transplantation.

Authors:  John A Hansen; Jason W Chien; Edus H Warren; Lue Ping Zhao; Paul J Martin
Journal:  Curr Opin Hematol       Date:  2010-11       Impact factor: 3.284

5.  Global variation in copy number in the human genome.

Authors:  Richard Redon; Shumpei Ishikawa; Karen R Fitch; Lars Feuk; George H Perry; T Daniel Andrews; Heike Fiegler; Michael H Shapero; Andrew R Carson; Wenwei Chen; Eun Kyung Cho; Stephanie Dallaire; Jennifer L Freeman; Juan R González; Mònica Gratacòs; Jing Huang; Dimitrios Kalaitzopoulos; Daisuke Komura; Jeffrey R MacDonald; Christian R Marshall; Rui Mei; Lyndal Montgomery; Kunihiro Nishimura; Kohji Okamura; Fan Shen; Martin J Somerville; Joelle Tchinda; Armand Valsesia; Cara Woodwark; Fengtang Yang; Junjun Zhang; Tatiana Zerjal; Jane Zhang; Lluis Armengol; Donald F Conrad; Xavier Estivill; Chris Tyler-Smith; Nigel P Carter; Hiroyuki Aburatani; Charles Lee; Keith W Jones; Stephen W Scherer; Matthew E Hurles
Journal:  Nature       Date:  2006-11-23       Impact factor: 49.962

6.  Allogeneic HY antibodies detected 3 months after female-to-male HCT predict chronic GVHD and nonrelapse mortality in humans.

Authors:  Hideki Nakasone; Lu Tian; Bita Sahaf; Takakazu Kawase; Kelsi Schoenrock; Spenser Perloff; Christine E Ryan; Jed Paul; Rakesh Popli; Fang Wu; Joanne M Otani; John Coller; Edus H Warren; David B Miklos
Journal:  Blood       Date:  2015-03-12       Impact factor: 22.113

7.  Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome.

Authors:  Neal Flomenberg; Lee Ann Baxter-Lowe; Dennis Confer; Marcelo Fernandez-Vina; Alexandra Filipovich; Mary Horowitz; Carolyn Hurley; Craig Kollman; Claudio Anasetti; Harriet Noreen; Ann Begovich; William Hildebrand; Effie Petersdorf; Barbara Schmeckpeper; Michelle Setterholm; Elizabeth Trachtenberg; Thomas Williams; Edmond Yunis; Daniel Weisdorf
Journal:  Blood       Date:  2004-06-10       Impact factor: 22.113

8.  Adaptive evolution of UGT2B17 copy-number variation.

Authors:  Yali Xue; Donglin Sun; Allan Daly; Fengtang Yang; Xue Zhou; Mengyao Zhao; Ni Huang; Tatiana Zerjal; Charles Lee; Nigel P Carter; Matthew E Hurles; Chris Tyler-Smith
Journal:  Am J Hum Genet       Date:  2008-08-28       Impact factor: 11.025

9.  UGT2B17 minor histocompatibility mismatch and clinical outcome after HLA-identical sibling donor stem cell transplantation.

Authors:  N Santos; R Rodríguez-Romanos; J B Nieto; I Buño; C Vallejo; A Jiménez-Velasco; S Brunet; E Buces; J López-Jiménez; M González; C Ferrá; A Sampol; R de la Cámara; C Martínez; D Gallardo
Journal:  Bone Marrow Transplant       Date:  2015-09-14       Impact factor: 5.483

10.  Phenotype frequencies of autosomal minor histocompatibility antigens display significant differences among populations.

Authors:  Eric Spierings; Matthijs Hendriks; Léna Absi; Angelica Canossi; Sonal Chhaya; John Crowley; Harry Dolstra; Jean-François Eliaou; Tom Ellis; Jürgen Enczmann; Maria E Fasano; Thibaut Gervais; Clara Gorodezky; Brigitte Kircher; David Laurin; Mary S Leffell; Pascale Loiseau; Mari Malkki; Miroslaw Markiewicz; Miryam Martinetti; Etsuko Maruya; Narinder Mehra; Fatma Oguz; Machteld Oudshoorn; Noemi Pereira; Rajni Rani; Ruhena Sergeant; Jackie Thomson; Thuong Hien Tran; Hannu Turpeinen; Kuo-Liang Yang; Renata Zunec; Mary Carrington; Peter de Knijff; Els Goulmy
Journal:  PLoS Genet       Date:  2007-06       Impact factor: 5.917
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.